U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Adenocarcinoma

MedGen UID:
1702262
•Concept ID:
C5204532
•
Neoplastic Process

Definition

An adenocarcinoma that has recurred after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Adenocarcinoma

Professional guidelines

PubMed

Efficacy and safety of full-thickness resection device based on over-the-scope clip system for resecting of gastric lesions in selected patients. Case series from a referral center for gastrointestinal diseases treatment and literature overview.
Bisogni D, Manetti R, Talamucci L, Staderini F, Coratti F, Rossi M, Naspetti R
G Chir 2019 Nov-Dec;40(6):569-577. PMID: 32007122
Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lung.
Handorf EA, McElligott S, Vachani A, Langer CJ, Bristol Demeter M, Armstrong K, Asch DA
J Oncol Pract 2012 Sep;8(5):267-74. Epub 2012 Jun 19 doi: 10.1200/JOP.2011.000502. PMID: 23277762Free PMC Article
Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
Morris M, Alvarez RD, Kinney WK, Wilson TO
Gynecol Oncol 1996 Feb;60(2):288-91. doi: 10.1006/gyno.1996.0040. PMID: 8631553

Recent clinical studies

Etiology

Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival.
Bedmutha AS, Agrawal A, Rangarajan V, Goel M, Patkar S, Puranik AD, Ramadwar M, Purandare NC, Shah S, Choudhury S
Jpn J Radiol 2023 Feb;41(2):201-208. Epub 2022 Sep 19 doi: 10.1007/s11604-022-01340-8. PMID: 36121626
Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial.
Kawazoe A, Fukuoka S, Nakamura Y, Kuboki Y, Wakabayashi M, Nomura S, Mikamoto Y, Shima H, Fujishiro N, Higuchi T, Sato A, Kuwata T, Shitara K
Lancet Oncol 2020 Aug;21(8):1057-1065. Epub 2020 Jun 23 doi: 10.1016/S1470-2045(20)30271-0. PMID: 32589866
Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn's disease.
Weber NK, Fletcher JG, Fidler JL, Barlow JM, Pruthi S, Loftus EV Jr, Pardi DS, Smyrk TC, Becker BD, Pasha SF, Bruining DH
Abdom Imaging 2015 Jun;40(5):1060-7. doi: 10.1007/s00261-014-0144-7. PMID: 24760323
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD
Ann Surg 1999 May;229(5):729-37; discussion 737-8. doi: 10.1097/00000658-199905000-00016. PMID: 10235532Free PMC Article
Cervical adenocarcinoma in situ.
Hopkins MP, Roberts JA, Schmidt RW
Obstet Gynecol 1988 Jun;71(6 Pt 1):842-4. PMID: 3285263

Diagnosis

Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival.
Bedmutha AS, Agrawal A, Rangarajan V, Goel M, Patkar S, Puranik AD, Ramadwar M, Purandare NC, Shah S, Choudhury S
Jpn J Radiol 2023 Feb;41(2):201-208. Epub 2022 Sep 19 doi: 10.1007/s11604-022-01340-8. PMID: 36121626
Histopathological Subtypes and PD-L1 Expression in Primary Urethral Adenocarcinoma: A Series of 5 Cases.
Padilla-Ansala C, García-Fernández E, González-Peramato P
Int J Surg Pathol 2021 Aug;29(5):488-495. Epub 2021 Jan 19 doi: 10.1177/1066896920988348. PMID: 33463392
A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Ghosh T, Duncavage E, Mehta-Shah N, McGuire PA, Tenenbaum M, Myckatyn TM
Aesthet Surg J 2020 Nov 19;40(12):1288-1300. doi: 10.1093/asj/sjz377. PMID: 31894234
Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lung.
Handorf EA, McElligott S, Vachani A, Langer CJ, Bristol Demeter M, Armstrong K, Asch DA
J Oncol Pract 2012 Sep;8(5):267-74. Epub 2012 Jun 19 doi: 10.1200/JOP.2011.000502. PMID: 23277762Free PMC Article
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD
Ann Surg 1999 May;229(5):729-37; discussion 737-8. doi: 10.1097/00000658-199905000-00016. PMID: 10235532Free PMC Article

Therapy

Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial.
Kawazoe A, Fukuoka S, Nakamura Y, Kuboki Y, Wakabayashi M, Nomura S, Mikamoto Y, Shima H, Fujishiro N, Higuchi T, Sato A, Kuwata T, Shitara K
Lancet Oncol 2020 Aug;21(8):1057-1065. Epub 2020 Jun 23 doi: 10.1016/S1470-2045(20)30271-0. PMID: 32589866
A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Ghosh T, Duncavage E, Mehta-Shah N, McGuire PA, Tenenbaum M, Myckatyn TM
Aesthet Surg J 2020 Nov 19;40(12):1288-1300. doi: 10.1093/asj/sjz377. PMID: 31894234
Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lung.
Handorf EA, McElligott S, Vachani A, Langer CJ, Bristol Demeter M, Armstrong K, Asch DA
J Oncol Pract 2012 Sep;8(5):267-74. Epub 2012 Jun 19 doi: 10.1200/JOP.2011.000502. PMID: 23277762Free PMC Article
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD
Ann Surg 1999 May;229(5):729-37; discussion 737-8. doi: 10.1097/00000658-199905000-00016. PMID: 10235532Free PMC Article
Cimetidine-associated thrombocytopenia.
Mann HJ, Schneider JR, Miller JB, Delaney JP
Drug Intell Clin Pharm 1983 Feb;17(2):126-8. doi: 10.1177/106002808301700209. PMID: 6825566

Prognosis

Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival.
Bedmutha AS, Agrawal A, Rangarajan V, Goel M, Patkar S, Puranik AD, Ramadwar M, Purandare NC, Shah S, Choudhury S
Jpn J Radiol 2023 Feb;41(2):201-208. Epub 2022 Sep 19 doi: 10.1007/s11604-022-01340-8. PMID: 36121626
Histopathological Subtypes and PD-L1 Expression in Primary Urethral Adenocarcinoma: A Series of 5 Cases.
Padilla-Ansala C, García-Fernández E, González-Peramato P
Int J Surg Pathol 2021 Aug;29(5):488-495. Epub 2021 Jan 19 doi: 10.1177/1066896920988348. PMID: 33463392
Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery.
Isaka T, Nakayama H, Ito H, Yokose T, Yamada K, Masuda M
BMC Cancer 2018 Oct 5;18(1):959. doi: 10.1186/s12885-018-4849-9. PMID: 30290774Free PMC Article
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD
Ann Surg 1999 May;229(5):729-37; discussion 737-8. doi: 10.1097/00000658-199905000-00016. PMID: 10235532Free PMC Article
Cimetidine-associated thrombocytopenia.
Mann HJ, Schneider JR, Miller JB, Delaney JP
Drug Intell Clin Pharm 1983 Feb;17(2):126-8. doi: 10.1177/106002808301700209. PMID: 6825566

Clinical prediction guides

Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival.
Bedmutha AS, Agrawal A, Rangarajan V, Goel M, Patkar S, Puranik AD, Ramadwar M, Purandare NC, Shah S, Choudhury S
Jpn J Radiol 2023 Feb;41(2):201-208. Epub 2022 Sep 19 doi: 10.1007/s11604-022-01340-8. PMID: 36121626
Histopathological Subtypes and PD-L1 Expression in Primary Urethral Adenocarcinoma: A Series of 5 Cases.
Padilla-Ansala C, García-Fernández E, González-Peramato P
Int J Surg Pathol 2021 Aug;29(5):488-495. Epub 2021 Jan 19 doi: 10.1177/1066896920988348. PMID: 33463392
Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial.
Kawazoe A, Fukuoka S, Nakamura Y, Kuboki Y, Wakabayashi M, Nomura S, Mikamoto Y, Shima H, Fujishiro N, Higuchi T, Sato A, Kuwata T, Shitara K
Lancet Oncol 2020 Aug;21(8):1057-1065. Epub 2020 Jun 23 doi: 10.1016/S1470-2045(20)30271-0. PMID: 32589866
Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn's disease.
Weber NK, Fletcher JG, Fidler JL, Barlow JM, Pruthi S, Loftus EV Jr, Pardi DS, Smyrk TC, Becker BD, Pasha SF, Bruining DH
Abdom Imaging 2015 Jun;40(5):1060-7. doi: 10.1007/s00261-014-0144-7. PMID: 24760323
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD
Ann Surg 1999 May;229(5):729-37; discussion 737-8. doi: 10.1097/00000658-199905000-00016. PMID: 10235532Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...